Trastuzumab Deruxtecan (Enhertu)

trastuzumab deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Trastuzumab Deruxtecan (Enhertu), covering 2026-01-08 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea